Abstract: A refrigerant circulation device includes a housing including an opening, a protrusion protruding from the housing, and a pump movable in a first direction in an internal space of the housing through the opening and mounted at a mounting position on one side in the first direction relative to the opening. The pump includes a stopper movable between a first position that does not overlap with the protrusion and a second position that overlaps with the protrusion and is on one side in the first direction relative to the protrusion.

Abstract: An electrically driven vehicle includes a floor panel, a tunnel section, an electrical storage device, and an electric power line. The tunnel section is formed in a vehicle forward/rearward direction in a central portion of the floor panel in a vehicle width direction. The electrical storage device is disposed behind the tunnel section of the vehicle above the floor panel. The electric power line is disposed below the tunnel section and connected to the electrical storage device. The tunnel section has an opening portion formed in a rear end portion of the tunnel section located in front of the electrical storage device of the vehicle and through which the electric power line is inserted.

Abstract: [Problem] The present invention pertains to a safer and more effective respiratory infection treating agent. [Solution] A respiratory infection treating agent containing, as an active ingredient, 7-[(3S,4S)-3-{(cyclopropylamino)methyl}-4-fluoropyrrolidine-1-yl]-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquin oline-3-carboxylic acid or a pharmaceutically acceptable salt thereof.

Abstract: [Problem] The present invention pertains to a safer and more effective respiratory infection treating agent. [Solution] A respiratory infection treating agent containing, as an active ingredient, 7-[(3S,4S)-3-{(cyclopropylamino)methyl}-4-fluoropyrrolidine-1-yl]-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or a pharmaceutically acceptable salt thereof.

Abstract: [Problem] The present invention pertains to a safer and more effective respiratory infection treating agent. [Solution] A respiratory infection treating agent containing, as an active ingredient, 7-[(3S,4S)-3-{(cyclopropylamino)methyl}-4-fluoropyrrolidine-1-yl]-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or a pharmaceutically acceptable salt thereof.

Abstract: [Problem] The present invention pertains to a safer and more effective respiratory infection treating agent. [Solution] A respiratory infection treating agent containing, as an active ingredient, 7-[(3S,4S)-3-{(cyclopropylamino)methyl}-4-fluoropyrrolidine-1-yl]-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or a pharmaceutically acceptable salt thereof.